DiaCarta SARS-CoV-2 Test Kit Receives CE Mark

Molecular diagnostic firm and UF Innovate | Sid Martin Biotech alum DiaCarta said that its QuantiVirus SARS-CoV-2 test recently received the CE mark. The firm has also filed for Emergency Use Authorization of the test with the US Food and Drug Administration.

The company’s qRT-PCR test detects viral RNA extracted from nasopharyngeal swabs, oropharyngeal swabs, and sputum. It targets three genes of SARS-CoV-2: the N, Orf1ab, and E genes.

Learn more about DiaCarta SARS-CoV-2 Test Kit Receives CE Mark.